Alexis Hilts, BS, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV.

Colleen D. Powers, MD, Department of Dermatology, School of Medicine, University of Mississippi Medical Center, Jackson, MS.

Robert T. Brodell, MD, FAAD, Department of Dermatology, School of Medicine, University of Mississippi Medical Center, Jackson, MS.

Vinayak K. Nahar, MD, PhD, MS, Department of Dermatology, School of Medicine, and Department of Preventive Medicine, School of Medicine/John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS.

Robert T. Brodell has participated in multicenter clinical trials with CorEvitas (formerly Corrona) Psoriasis Registry and Novartis. Stock: Veradermics, Inc. He is also associate editor of the Journal of the American Academy of Dermatology, faculty advisor for the American Medical Student Research Journal, and editor in chief of Practice Update: Dermatology and serves as staff dermatologist at the GV (Sonny) Montgomery VA Hospital in Jackson, MS. Alexis Hilts, Colleen D. Powers, and Vinayak K. Nahar have no conflicts of interest.

Correspondence concerning this article should be addressed to Vinayak K. Nahar, MD, PhD, MS, Department of Dermatology, School of Medicine, University of Mississippi Medical Center, 2500 North State St – L216, Jackson, MS 39216. E-mail: [email protected]